Clinical Trial

CAP48 - Autism in Children and Adolescents

Study acronym: CAP48-ASD
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-20.
Trial Details
NCT Number NCT06149468
Lead Sponsor Université Catholique de Louvain
Collaborators: Université Libre de Bruxelles, Université de Namur, University of Mons, Université de Liège
Conditions Autism Spectrum Disorder
Enrollment 500 participants
Start Date 2023-09-15
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-29